FDA panel backs 2nd dose for J&J vaccine recipients


The FDA's Vaccines and Related Biological Products Advisory Committee has recommended that the agency authorize a second dose of Johnson & Johnson's COVID-19 vaccine as a booster for all people who received J&J's single-dose vaccine. The panel recommended that the second dose be administered at least two months after administration of the first shot, though the FDA still has to make a final decision on the matter.

Full story:

SNMMI SmartBrief

Nuclear medicine, molecular imaging and therapy

Designed specifically for nuclear medicine and molecular imaging professionals, SNMMI SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news and information to save you time and keep you informed on our profession.